The need to adopt patient-centric clinical trials has never been more acute for pharmaceutical organizations worldwide. One of the biggest learnings from the pandemic was the tremendous potential held by digital technologies to enable remote and personalized clinical trials, also referred to as decentralized trials, in order to achieve trial continuity and operational efficiencies. With advancement in technology, proactive guidance from regulators and a surge in wearable and devices, adoption of decentralized trials has slowly become a must-have rather than a 'good-to-have' initiative.
TCS ADD™ Connected Clinical Trials (CCT), a part of TCS ADD suite of platforms, provides a unified interface for patients and sites and incorporates modern technologies and collaboration to enable next-generation patient-centric trials. The flexible and modular platform provides capabilities for electronic and multimedia consenting, virtually connects diverse trial stakeholders, facilitates digital labels, provides a visibility to clinical supply management, provides personalized and real-time alerts to patients and physicians on medication management and ensure medication adherence, provisions automated data collection from various smart devices and tracks trial activities to enhance data quality and patient safety. In addition, TCS ADD™ CCT is equipped to prevent adverse events, provides ecosystems for healthcare partners to symbiotically connect, and facilitates advanced data modeling and insights backed by AI, ML and cognitive analytics.
TCS ADD™ Connected Clinical Trials Solutions
Digitized clinical trial supply management solution putting the patient in the center
eCOA, Diaries, and Surveys
Highly configurable solution with a rich library of personalized and multimedia engagement tools
Secure end-to-end consent solution supporting paper based and e-signature, embedded with multimedia engagement tools
Device agnostic, seamless, multi-tenant, and feature-rich televisit functionality for patients, sites, and sponsors
Devices and Wearables
Biometric sensors with connected medical devices for timely and accurate health insights through automated data collection and remote monitoring
Personalized patient and site support throughout the trial process via portals, apps, and multimedia literature